Le Lézard
Classified in: Health, Science and technology
Subjects: CALENDAR OF EVENTS, HEALTH

Media Advisory: Top Smoking Cessation Experts Meet in Ottawa


OTTAWA, Jan. 18, 2019 (GLOBE NEWSWIRE) -- National and international smoking cessation authorities are gathering in Ottawa today to attend the 11th Annual Ottawa Conference: State of the Art Clinical Approaches to Smoking Cessation, Canada's premier event promoting the latest ideas and evidence in clinical tobacco treatment, program development and smoking cessation research. This year's proceedings take place ahead of National Non-Smoking Week, January 20-26.

CONFERENCE DETAILS

WHAT: The 11th Annual Ottawa Conference: State of the Art Clinical Approaches to Smoking Cessation
WHEN: Today and tomorrow (Jan. 18-19)
WHERE: Shaw Centre, 55 Colonel By Dr, Ottawa, ON K1N 9J2

TODAY'S HOT TOPICS

Visit the OMSC website for detailed information including timings and locations of all proceedings.

TO COORDINATE INTERVIEWS WITH KEY EXPERTS, PLEASE CONTACT:

Leigh B. Morris
Communications Officer
University of Ottawa Heart Institute
613-316-6409 (cell)
[email protected]


These press releases may also interest you

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:07
MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the Document Solutions v7.1 release. This release introduces features and enhancements to MESCIUS's server-side document APIs, JavaScript...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...

at 07:05
Enterprises in France, seeking better returns on investment, are turning to service providers that can manage their Salesforce platforms more efficiently, according to a new research report published today by Information Services Group (ISG) , a...



News published on and distributed by: